Cargando…

“The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained

Cannabis, as a natural medicinal remedy, has long been used for palliative treatment to alleviate the side effects caused by diseases. Cannabis-based products isolated from plant extracts exhibit potent immunoregulatory properties, reducing chronic inflammatory processes and providing much needed pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoury, Mona, Cohen, Idan, Bar-Sela, Gil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877666/
https://www.ncbi.nlm.nih.gov/pubmed/35214123
http://dx.doi.org/10.3390/pharmaceutics14020389
_version_ 1784658474273079296
author Khoury, Mona
Cohen, Idan
Bar-Sela, Gil
author_facet Khoury, Mona
Cohen, Idan
Bar-Sela, Gil
author_sort Khoury, Mona
collection PubMed
description Cannabis, as a natural medicinal remedy, has long been used for palliative treatment to alleviate the side effects caused by diseases. Cannabis-based products isolated from plant extracts exhibit potent immunoregulatory properties, reducing chronic inflammatory processes and providing much needed pain relief. They are a proven effective solution for treatment-based side effects, easing the resulting symptoms of the disease. However, we discuss the fact that cannabis use may promote the progression of a range of malignancies, interfere with anti-cancer immunotherapy, or increase susceptibility to viral infections and transmission. Most cannabis preparations or isolated active components cause an overall potent immunosuppressive impact among users, posing a considerable hazard to patients with suppressed or compromised immune systems. In this review, current knowledge and perceptions of cannabis or cannabinoids and their impact on various immune-system components will be discussed as the “two sides of the same coin” or “double-edged sword”, referring to something that can have both favorable and unfavorable consequences. We propose that much is still unknown about adverse reactions to its use, and its integration with medical treatment should be conducted cautiously with consideration of the individual patient, effector cells, microenvironment, and the immune system.
format Online
Article
Text
id pubmed-8877666
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88776662022-02-26 “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained Khoury, Mona Cohen, Idan Bar-Sela, Gil Pharmaceutics Review Cannabis, as a natural medicinal remedy, has long been used for palliative treatment to alleviate the side effects caused by diseases. Cannabis-based products isolated from plant extracts exhibit potent immunoregulatory properties, reducing chronic inflammatory processes and providing much needed pain relief. They are a proven effective solution for treatment-based side effects, easing the resulting symptoms of the disease. However, we discuss the fact that cannabis use may promote the progression of a range of malignancies, interfere with anti-cancer immunotherapy, or increase susceptibility to viral infections and transmission. Most cannabis preparations or isolated active components cause an overall potent immunosuppressive impact among users, posing a considerable hazard to patients with suppressed or compromised immune systems. In this review, current knowledge and perceptions of cannabis or cannabinoids and their impact on various immune-system components will be discussed as the “two sides of the same coin” or “double-edged sword”, referring to something that can have both favorable and unfavorable consequences. We propose that much is still unknown about adverse reactions to its use, and its integration with medical treatment should be conducted cautiously with consideration of the individual patient, effector cells, microenvironment, and the immune system. MDPI 2022-02-10 /pmc/articles/PMC8877666/ /pubmed/35214123 http://dx.doi.org/10.3390/pharmaceutics14020389 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Khoury, Mona
Cohen, Idan
Bar-Sela, Gil
“The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
title “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
title_full “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
title_fullStr “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
title_full_unstemmed “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
title_short “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
title_sort “the two sides of the same coin”—medical cannabis, cannabinoids and immunity: pros and cons explained
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877666/
https://www.ncbi.nlm.nih.gov/pubmed/35214123
http://dx.doi.org/10.3390/pharmaceutics14020389
work_keys_str_mv AT khourymona thetwosidesofthesamecoinmedicalcannabiscannabinoidsandimmunityprosandconsexplained
AT cohenidan thetwosidesofthesamecoinmedicalcannabiscannabinoidsandimmunityprosandconsexplained
AT barselagil thetwosidesofthesamecoinmedicalcannabiscannabinoidsandimmunityprosandconsexplained